<html>
<head>PUBMED IDs for B-MYB</head>
<body bgcolor='#C5F0F2'><h1>B-MYB</h1><a href='https://pubmed.ncbi.nlm.nih.gov/2160970/'>DNA binding activity and transcriptional activator function of the human B-myb protein compared with c-MYB.</a> June 5  1990<br><a href='https://pubmed.ncbi.nlm.nih.gov/1409626/'>Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase.</a> October 1  1992<br><a href='https://pubmed.ncbi.nlm.nih.gov/9012818/'>Activation of human B-MYB by cyclins.</a> January 21  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/10022815/'>B-MYB transactivates its own promoter through SP1-binding sites.</a> February 18  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10770937/'>Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB.</a> April 20  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11016623/'>Pleiotropic resistance to DNA-interactive drugs is associated with increased expression of genes involved in DNA replication, repair, and stress response.</a> October 4  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11781832/'>PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites.</a> January 10  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12645566/'>Enhancement of B-MYB transcriptional activity by ZPR9, a novel zinc finger protein.</a> March 21  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12645549/'>The gene patenting controversy: a convergence of law, economic interests, and ethics.</a> March 21  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15618219/'>Temperature-dependent modification and activation of B-MYB: implications for cell survival.</a> December 25  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15738394/'>Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors.</a> March 2  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16198555/'>B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer.</a> October 4  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17159899/'>The human synMuv-like protein LIN-9 is required for transcription of G2/M genes and for entry into mitosis.</a> December 13  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17182682/'>Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence.</a> December 22  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17452517/'>The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children.</a> April 25  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17671431/'>LINC, a human complex that is related to pRB-containing complexes in invertebrates regulates the expression of G2/M genes.</a> August 3  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18026132/'>Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk.</a> November 21  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19383908/'>B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.</a> July 15  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19562686/'>Stem cell pluripotency: a cellular trait that depends on transcription factors, chromatin state and a checkpoint deficient cell cycle.</a> August 29  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19725879/'>LIN54 is an essential core subunit of the DREAM/LINC complex that binds to the cdc2 promoter in a sequence-specific manner.</a> October 23  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20734103/'>B-MYB delays cell aging by repressing p16 (INK4Î±) transcription.</a> April 9  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21270603/'>MYBL2 (B-MYB) in cervical cancer: putative biomarker.</a> July 2  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21304178/'>Addiction of MYCN amplified tumours to B-MYB underscores a reciprocal regulatory loop.</a> August 25  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21304174/'>Addiction to B-MYB.</a> August 25  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21969598/'>Animal-specific C-terminal domain links myeloblastosis oncoprotein (Myb) to an ancient repressor complex.</a> December 31  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22619121/'>A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma.</a> October 13  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23555285/'>Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB.</a> June 26  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/26308378/'>ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma.</a> August 3  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26384566/'>The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes.</a> June 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27280975/'>Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks.</a> June 6  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28034748/'>MiR-216a decreases MALAT1 expression, induces G2/M arrest and apoptosis in pancreatic cancer cells.</a> December 31  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28559119/'>Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma.</a> June 1  2017<br></body></html>
